Syria’s First Lady To Withdraw From Public Duty To Treat Leukaemia – Presidency
Joy ChukwuMay 21, 20241 Mins read779 
Asma al-Assad, Syria’s first lady, has been diagnosed with leukaemia, the Syrian presidency announced in a statement on Tuesday.
“First Lady Asma al-Assad has been diagnosed with acute myeloid leukaemia,” the statement read.
It revealed that she “will undergo a specialised treatment protocol” that requires social distancing to avoid infection, adding that she will “temporarily withdraw from all direct engagements as part of her treatment plan”.
Acute myeloid leukaemia is an aggressive cancer of the bone marrow and the blood.
Assad has previously been treated for breast cancer. In August 2019, she announced that she was “completely” free of the disease a year after her diagnosis.
About The Author
Related Articles
ECOWAS Calls for Short, Inclusive Political Transition in Guinea-Bissau
The Economic Community of West African States (ECOWAS) has reiterated its call...
Niger Adopts Record 2026 Budget in Push for Economic Sovereignty
Niger has approved a record national budget of more than 2.922 trillion...
Niger Records Progress on Dasa Uranium Project, Strengthens Gold Ambitions
Niger is recording major advances in its mining sector, with significant progress...
Africa’s Largest Airport Takes Shape as Ethiopia Commences $12.5bn Build
Ethiopia has officially begun work on a massive new airport that officials...